Vumerity reduces relapses, lesions over 2 years: EVOLVE-MS-1
Just about two years of remedy with Vumerity (diroximel fumarate) considerably diminished relapse charges by way of greater than 80% in folks with relapsing-remitting more than one sclerosis (RRMS), in step with
